Gov't Bid To Undo Arthrex-Based Remand Flops At Fed. Circ.
Law360 (February 25, 2020, 8:25 PM EST) -- The full Federal Circuit has left in place a panel decision vacating the Patent Trial and Appeal Board’s invalidation of a technology licensing company’s patent, shrugging off warnings from the U.S. Patent and Trademark Office that the court is "reflexively" invoking Arthrex.
Both the original panel and en banc court refused Monday to rehear the December decision, which gave Image Processing Technologies LLC another chance to defend its image processing patent from a pair of Samsung Electronics Co. Ltd.’s challenges. The court didn’t expand on its decision.
The Federal Circuit had vacated a pair of PTAB’s rulings from 2018 invalidating claims of...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!